RAM
PFE icon

Readystate Asset Management’s Pfizer PFE Stock Holding History

Readystate Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+9,927
New +$260K 0.01% 800
2025
Q1 		– Sell
-39,346
Closed -$1.03M – 707
2024
Q4 		$1.04M Buy
+39,346
New +$1.07M 0.03% 389

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Readystate Asset Management's PFE Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 9,927 shares worth $239K. The stake represents 0.01% of the portfolio and ranks #800 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in PFE as recently as Q4 2024.

Readystate Asset Management first reported a position in PFE in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.04M in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Readystate Asset Management held 9,927 shares of Pfizer worth $239K as of Q2 2026.
  • Pfizer was a new Readystate Asset Management position in Q2 2026.
  • Pfizer made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #800 holding.
  • Readystate Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 2 quarters since.
  • Readystate Asset Management's Pfizer position peaked at $1.04M in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.